Irritable Bowel Syndrome (IBS): What It Is, Why It Happens, and How It's Managed
A disorder of gut-brain interaction — what IBS is, why it happens, and how it's managed.

Short Answer
Irritable bowel syndrome (IBS) is a common, long-term condition of how your gut and brain communicate — a disorder of gut-brain interaction — that can make your abdomen hurt and change how often you poop, how urgent it feels, and what your stool looks like. It is diagnosed by a pattern of symptoms, not by one scan or one blood test: as one 2026 review puts it, "Irritable bowel syndrome, diagnosed using the ROME IV diagnostic criteria, is one of the most common dysfunctional disorders of the gastrointestinal system with a high global prevalence". In Rome IV, the core pattern is recurrent abdominal pain, on average at least 1 day a week in the last 3 months, linked with bowel movements and/or a change in stool frequency or form, with symptoms starting at least 6 months before diagnosis. (pubmed.ncbi.nlm.nih.gov)
The symptoms are real. They can be exhausting, embarrassing, and disruptive enough to shape your meals, commute, workday, and sleep. But IBS is not the same as inflammatory bowel disease, and it does not mean your bowel is being silently damaged: NIDDK describes IBS as pain plus bowel changes “without any visible signs of damage or disease” in the digestive tract, and Cleveland Clinic notes that IBS does not damage GI tissue or raise colon cancer risk. The same 2026 review notes that symptoms happen "without an associated increase in mortality risk". (niddk.nih.gov)
At the center of IBS is the two-way line between your gut and your nervous system: "Disruptions to the gut-brain axis, the bidirectional communication system between the central nervous system and the enteric nervous system, are hypothesised to be at the core of irritable bowel syndrome". That does not mean IBS is “just stress.” It means your intestinal nerves, motility, immune signaling, microbiome, stress-response system, and pain-processing circuits can amplify each other. In plain language: the gut sends louder signals, the brain and autonomic nervous system may react more strongly, and ordinary digestion can feel painful, urgent, bloated, or draining. Current reviews connect IBS with gut-brain axis dysregulation, visceral hypersensitivity, stress-response pathways, microbiome changes, and altered motility. (pmc.ncbi.nlm.nih.gov)
Management is usually layered because IBS is layered. Food changes can help, including a clinician-guided low-FODMAP trial for some people; medications may target constipation, diarrhea, cramping, or pain; and gut-directed behavioral therapies such as CBT or hypnotherapy can help calm the gut-brain loop for some patients. The right plan depends on your IBS subtype, red flags, medical history, and what you can realistically sustain. A wearable cannot diagnose IBS. But tracking sleep, stress, recovery, and symptom timing can help you notice your own flare patterns — the stretch of bad sleep before a bloating week, the high-pressure workday before urgency, the low-recovery run of days before pain ramps up — and bring cleaner context to a clinician. (niddk.nih.gov)
IBS and the gut-brain axis — what our data shows
Among 612 Welltory users who self-report IBS, compared with 3,533 users who do not, the clearest signal was not resting heart rate, HRV, sleep score, or recovery. It was how people felt. Brain fog showed up in 55% of IBS self-reports versus 21% of the comparison group. And the gap still held when we compared people with the same number of other self-reported conditions, which makes it less likely that the pattern is only about co-occurring health problems.
That fits the gut-brain framing. IBS often lives in the space where the body’s signals are real, loud, and hard to capture with a single lab or wearable number. In our data, the “hard” wearable metrics were nearly overlapping between groups: resting heart rate, morning HRV score, sleep score, and recovery did not separate people with self-reported IBS the way brain fog did. The practical takeaway is not “your wearable can detect IBS.” It cannot. The takeaway is that symptom tracking can catch burden that standard body metrics may miss — especially the day-to-day cognitive and energy load that many people experience alongside gut symptoms.
This is a first-party pattern from a self-identified group of Welltory users who self-report IBS — anonymized, aggregated data, not a clinical diagnosis, and not a way to diagnose IBS. See the “How we made it” note for methodology. All figures are reported as anonymized, aggregated data; no individual user is identifiable.
IBS at a glance
| Question | Short answer | Notes |
|---|---|---|
| What is it? | IBS is a disorder of gut-brain interaction: your bowel looks structurally normal, but the signaling between the gut, nerves, brain, immune system, microbiome, and muscles becomes easier to provoke. The result is recurring abdominal pain plus changes in bowel habits — constipation, diarrhea, or both — without bowel tissue damage. | "symptoms primarily manifest as abdominal pain, bloating, and alterations to bowel habits, negatively impacting quality of life but without an associated increase in mortality risk". Cleveland Clinic also frames IBS as a chronic, manageable condition that does not damage the GI tract or raise colon cancer risk. (pmc.ncbi.nlm.nih.gov) |
| How common is it? | It’s one of the most common gut conditions, but the number changes depending on which diagnostic criteria researchers use and where the study is done. A useful global shorthand is roughly 4–10%: one large global meta-analysis found 3.8% with Rome IV criteria and 9.2% with Rome III criteria. | "Irritable bowel syndrome (IBS) is one of the most common functional gastrointestinal disorders worldwide"; a 2026 meta-analysis found "The pooled prevalence of IBS in China was 11.0%". Cleveland Clinic cites U.S. adult estimates of about 10–15%, while global Rome-based estimates are lower when stricter Rome IV criteria are used. (pmc.ncbi.nlm.nih.gov) |
| What are the subtypes? | IBS is subtyped by stool pattern on days when bowel movements are abnormal: IBS-C means constipation-predominant, IBS-D diarrhea-predominant, IBS-M mixed constipation and diarrhea, and IBS-U unclassified. | "IBS symptoms such as IBS-C, IBS-D, IBS-M, and IBS-U". Rome IV subtype thresholds use the Bristol Stool Form Scale: IBS-C is >25% hard/lumpy stools and <25% loose/watery stools; IBS-D is the reverse; IBS-M is >25% hard/lumpy and >25% loose/watery; IBS-U meets IBS criteria but does not fit those stool-pattern groups. (pmc.ncbi.nlm.nih.gov) |
| Why does it happen? | IBS doesn’t have one single cause. The practical “why” is that the gut becomes easier to set off: gut nerves may over-read normal stretch or gas as pain, gut muscles may move too fast or too slowly, and stress, infection, hormones, foods, immune signaling, and microbiome shifts can all turn the volume up. | "the role of visceral hypersensitivity, altered brain-gut communication, and luminal factors such as gas and distension". Cleveland Clinic describes IBS as a neurogastrointestinal disorder — a disorder of gut-brain coordination — and highlights dysmotility and visceral hypersensitivity as key mechanisms. (pmc.ncbi.nlm.nih.gov) |
| How is it diagnosed? | IBS is diagnosed clinically, not by one definitive test. A clinician looks for the Rome IV pattern — recurrent abdominal pain, on average at least 1 day per week in the last 3 months, linked with at least two of: pain related to defecation, a change in stool frequency, or a change in stool form — with symptom onset at least 6 months before diagnosis. They also check for red flags that could point to another condition. | Diagnosed with Rome IV criteria. Published Rome IV summaries give the wording as: recurrent abdominal pain at least 1 day/week in the last 3 months, associated with two or more of defecation, stool-frequency change, and stool-form change; criteria should be met for the last 3 months, with symptoms starting at least 6 months before diagnosis. Red flags include rectal bleeding, unexplained weight loss, fever, vomiting, nighttime diarrhea, or severe pain that does not improve after passing stool or gas. (pmc.ncbi.nlm.nih.gov) |
| Can it be cured? | There’s no known cure right now, but IBS is usually manageable. The goal is to reduce flares, calm pain signaling, stabilize bowel habits, and identify your triggers — without treating IBS like it is damaging your bowel. | "there is currently no known cure for irritable bowel syndrome". Cleveland Clinic gives the same patient-facing bottom line: there isn’t a cure, but most people can manage symptoms with trigger avoidance, diet/routine changes, behavioral approaches, and medication when needed. (pmc.ncbi.nlm.nih.gov) |
What IBS is — a disorder of gut-brain interaction
IBS is not a sign that your bowel is being worn away, injured, or quietly turning into something more dangerous. It is better understood as a problem in coordination: your gut, immune signals, microbes, stress system, and nervous system are all part of a two-way network, and in IBS that network can become too reactive. The current medical name for this group of conditions is disorders of gut-brain interaction (DGBI) — conditions where symptoms come from how the brain and gut work together, even when routine tests do not show visible damage or disease. (niddk.nih.gov) As a 2026 review summarizes, "Disruptions to the gut-brain axis, the bidirectional communication system between the central nervous system and the enteric nervous system, are hypothesised to be at the core of irritable bowel syndrome". (pmc.ncbi.nlm.nih.gov)
In real life, that means ordinary digestion can feel amplified. Stretching from gas, normal movement of stool, a stressful week, poor sleep, a gut infection, or certain foods may set off stronger-than-expected pain, bloating, urgency, diarrhea, constipation, or a mix of both. Your bowel may look normal on scans or scopes because the main problem is not a structural lesion. It is signaling, sensitivity, motility, and how your gut-brain system interprets what is happening inside your abdomen. NIDDK describes IBS as repeated abdominal pain with changes in bowel movements, without visible signs of digestive-tract damage or disease. (niddk.nih.gov)
That framing matters. “Nothing showed up on the test” does not mean “nothing is happening.” IBS symptoms are real, body-based, and often disruptive. The same 2026 review describes IBS by its symptom pattern: "symptoms primarily manifest as abdominal pain, bloating, and alterations to bowel habits, negatively impacting quality of life but without an associated increase in mortality risk". (pubmed.ncbi.nlm.nih.gov) IBS can be miserable to live with, but by itself it does not damage the GI tract, does not raise colon cancer risk, and is not considered a condition that shortens life — as long as red-flag symptoms such as rectal bleeding, unexplained weight loss, nighttime diarrhea, iron-deficiency anemia, or persistent vomiting are checked rather than assumed to be IBS. (mayoclinic.org)
IBS symptoms and subtypes (IBS-C, IBS-D, IBS-M)
The cardinal symptom of IBS is abdominal pain. A 2026 review states plainly that "Abdominal pain is the cardinal symptom of irritable bowel syndrome (IBS) and the primary determinant of disease burden and healthcare utilization", and that pain is present "across all IBS subtypes". That pain can feel like cramping, pressure, sharp pain, burning, or a deep ache. It usually travels with bloating, gas, urgency, mucus, a feeling that you did not fully empty your bowel, and — most importantly for classification — a change in stool form or frequency. In other words, IBS is not just “constipation” or “diarrhea.” It is belly pain plus a bowel pattern that keeps misfiring. (my.clevelandclinic.org)
IBS is grouped into four subtypes by predominant stool pattern: "IBS symptoms such as IBS-C, IBS-D, IBS-M, and IBS-U" — that is, IBS-C (constipation-predominant), IBS-D (diarrhea-predominant), IBS-M (mixed, alternating between the two), and IBS-U (unclassified). Rome IV subtyping uses the Bristol Stool Form Scale on days when you have abnormal bowel movements: IBS-C means more than 25% hard/lumpy stools and less than 25% loose/watery stools; IBS-D means more than 25% loose/watery stools and less than 25% hard/lumpy stools; IBS-M means more than 25% of both; IBS-U means the stool pattern does not meet those cutoffs. Bristol types 1–2 count as hard/lumpy; types 6–7 count as loose/watery. (pmc.ncbi.nlm.nih.gov)
Knowing your subtype matters because treatment follows the bowel pattern. If your gut is moving too fast, the goal is often to calm urgency and loose stools. If it is moving too slowly, the goal is to soften stool and improve transit. If you alternate, your plan has to be more careful, because pushing hard in one direction can tip you into the other. That is why clinicians ask what your stools look like during flares, not just whether you “have IBS.” (my.clevelandclinic.org)
Flares. IBS symptoms come and go in waves. Some people have long quiet stretches; others flare after meals, specific foods, emotional stress, constipation, diarrhea, or no obvious trigger at all. Poor sleep can make your nervous system more reactive, and many people with IBS also report sleep disturbance, anxiety, migraine, pelvic pain, or other body-wide symptoms — another clue that IBS lives on the gut-brain axis, not only inside the bowel. (hopkinsmedicine.org)
Hormonal timing can matter too. Some people notice gut symptoms around the menstrual cycle, and PMS itself can include bloating, constipation, or diarrhea. That does not mean hormones “cause” IBS in everyone; it means the bowel is wired into systems that also respond to stress chemistry, sleep, pain sensitivity, and cyclic hormone shifts. Day to day, that is where the gut-brain link becomes tangible: your gut may react before you have words for what your body is under. (mayoclinic.org)
What causes IBS? Visceral hypersensitivity, stress, and the gut-brain link
There isn't one single cause. IBS is understood as several overlapping mechanisms converging on an oversensitive, dysregulated gut-brain system: the nerves in your gut send stronger signals, the brain interprets those signals differently, and the muscles of the bowel may move too fast, too slowly, or out of sync. That is why IBS can feel intensely physical even when tests do not show visible bowel damage. (niddk.nih.gov)
Visceral hypersensitivity means the gut is turned up too loud. A normal stretch from gas or stool can register as pain, pressure, cramping, or bloating because the gut’s pain pathways are more reactive than they should be. This is a core IBS mechanism, and it is specific enough that researchers are testing treatments against it: a 2026 randomized clinical trial of 124 adults with IBS-related abdominal pain noted that "increased T-type channels activity or expression contributes to visceral hypersensitivity in irritable bowel syndrome", then tested a T-type calcium channel blocker. The drug did not outperform placebo in the main analysis and was harder to tolerate, so this is not a treatment recommendation — it is evidence that IBS pain is being studied as a real nerve-signaling problem, not “just stress.” (pubmed.ncbi.nlm.nih.gov)
Stress, anxiety, and the gut-brain axis matter because the gut and brain are wired together. Stress hormones can change motility, barrier function, immune signaling, and pain sensitivity; in a sensitized gut, that can mean more urgency, constipation, diarrhea, bloating, or pain during stressful periods. The same review that anchors the definition describes the loop directly: "chronic stress and anxiety may significantly exacerbate symptoms through the upregulation of cortisol secretion, disrupting the gut microbiome and elevating visceral sensitivity". This is the mechanistic bridge to Welltory's angle — stress, HRV, and sleep are measurable, and they sit on the same axis that can drive IBS symptoms, even though they do not diagnose IBS by themselves (see anxiety and cortisol). (pmc.ncbi.nlm.nih.gov)
Other contributors can stack on top of that gut-brain sensitivity. The gut microbiome may differ in people with IBS; food intolerances or sensitivities can trigger symptoms; genetics may make some people more vulnerable; and altered motility can push bowel movements toward diarrhea, constipation, or both. IBS can also start after a gut infection — post-infectious IBS — when bacteria, viruses, or parasites disrupt the gut microbiome and immune system after enteritis or gastroenteritis. (mayoclinic.org)
How IBS is diagnosed
Because there isn’t a single scan, scope, or blood test that can prove IBS, the diagnosis usually starts with your story: where the pain is, how often it happens, what your stools look like, and whether pain shifts when you poop. NICE explains this as a symptom-based diagnosis, with blood tests used to check for anemia, inflammation, and celiac disease rather than to “confirm” IBS itself. (nice.org.uk)
Many current IBS studies still identify people using the Rome IV criteria — the same symptom framework used in the research cited here: "Presence of bowel DGBI was determined using Rome IV criteria" and "using the ROME IV diagnostic criteria". In Rome IV terms, IBS means recurrent abdominal pain, on average at least 1 day per week in the last 3 months, linked with at least 2 of these: pain related to defecation, a change in stool frequency, or a change in stool form or appearance; the pattern should have started at least 6 months before diagnosis. (pmc.ncbi.nlm.nih.gov)
A good IBS diagnosis also asks, “What else could look like this?” Celiac disease, inflammatory bowel disease, infections, microscopic colitis, colorectal cancer, and pelvic-floor problems can all overlap with IBS symptoms, so your clinician may order targeted tests depending on your bowel pattern, age, exam, and risk factors. That does not mean your symptoms are being dismissed. It means the label “IBS” is safest when the pattern fits and warning signs are not pointing somewhere else. (ncbi.nlm.nih.gov)
Red flags are the symptoms that should not be waved away as “just IBS”: blood from the rectum or black/tarry stool, unintended or unexplained weight loss, iron-deficiency anemia or other concerning lab abnormalities, fever or night sweats, diarrhea that wakes you from sleep, new symptoms starting at age 50 or older, a recent clear change in bowel habit, an abdominal or rectal mass, or a family history of colorectal cancer, inflammatory bowel disease, or celiac disease. NICE specifically recommends further evaluation when red-flag indicators or inflammatory markers for IBD are present, and its patient guidance highlights unexplained weight loss, rectal bleeding, family history of bowel or ovarian cancer, and late-onset bowel-habit change in older adults as reasons to consider referral. (nice.org.uk)
IBS treatment: diet, gut-brain therapies, and medication
There is no cure for IBS, but that does not mean “nothing can be done.” It means treatment has to be layered: reduce the bowel triggers you can identify, calm the gut-brain stress loop that amplifies pain and urgency, and use medicines when symptoms need more direct control. "there is currently no known cure for irritable bowel syndrome" The goal is not to “fix” a damaged bowel — IBS does not work like that — but to make your gut less reactive and your days more predictable. For a full treatment and medication guide, see our IBS treatment page. (pmc.ncbi.nlm.nih.gov)
Diet, including the low-FODMAP approach
Diet is usually one of the first non-drug levers because food changes the physical environment inside your gut: it can pull water into the bowel, feed bacterial fermentation, stretch the intestinal wall with gas, and trigger pain signals in a hypersensitive gut. NICE recommends general diet and lifestyle advice first, then further dietary management — including a low-FODMAP diet — if symptoms persist, and says this more restrictive advice should come from a healthcare professional with expertise in diet management. (nice.org.uk)
The most studied IBS diet is the low-FODMAP diet. "The low FODMAP diet (fermentable oligosaccharides, disaccharides, monosaccharides and polyols, LFD)" "is used in patients diagnosed with Irritable Bowel Syndrome (IBS) as part of non-pharmacological treatment". It is not meant to be a forever “clean eating” plan. It works as a structured experiment: first you reduce high-FODMAP foods, then you reintroduce them one by one, then you personalize your usual diet around what your gut actually tolerates. Patient-facing clinical resources describe the same three-step logic — elimination, reintroduction, and personalization — and emphasize that triggers vary from person to person. (pmc.ncbi.nlm.nih.gov)
The evidence is supportive, but not magic-wand perfect. In a 2021 meta-analysis of 10 randomized trials, a low-FODMAP diet improved global IBS symptoms compared with control diets (RR 1.54, 95% CI 1.18–2.00), while a network meta-analysis of 13 trials ranked it highly for global symptoms, abdominal pain, bloating/distension, and bowel habit outcomes. A newer 2025 meta-analysis found a smaller, statistically uncertain estimate for global symptom improvement (RR 1.21, 95% CI 0.98–1.51), which is a good reminder that results depend on the comparator diet, study design, adherence, and whether the diet is done carefully. (pubmed.ncbi.nlm.nih.gov)
That is why the “how” matters. A low-FODMAP plan is restrictive enough to create nutritional gaps or unnecessary food fear if you stay in the elimination phase too long. The practical goal is not to eat the smallest possible list of foods; it is to find the broadest diet your gut can handle. Low-FODMAP vegetables, fruits, grains, proteins, and snacks can make the first phase doable, but the reintroduction phase is where the plan becomes useful for real life. (pmc.ncbi.nlm.nih.gov)
Gut-brain and stress-directed therapies
Because IBS runs through the gut-brain axis, psychological therapies are genuine gut treatments, not “it’s all in your head” add-ons. Stress signals can alter motility, secretion, immune tone, gut permeability, microbiome patterns, and visceral sensitivity — the volume knob on gut pain. When that loop is active, a normal amount of gas, stool movement, or stretching can feel urgent, painful, or exhausting. (pmc.ncbi.nlm.nih.gov)
Cognitive behavioral therapy is effective here but underused: "Cognitive behavioral therapy (CBT) is an effective but underutilized treatment for bowel disorders of gut-brain interaction". ACG suggests gut-directed psychotherapy for global IBS symptoms, NIDDK lists CBT, gut-directed hypnotherapy, and relaxation training among mental health therapies used for IBS, and NICE says CBT, hypnotherapy, and/or psychological therapy should be considered for people with refractory IBS after a long period of nonresponse to pharmacological treatment. (pubmed.ncbi.nlm.nih.gov)
Gut-directed hypnotherapy and stress-management approaches sit in the same body-first logic: they train the nervous system to send safer signals to the gut and to interpret gut sensations with less alarm. That does not make symptoms imaginary. It means the bowel and brain are part of the same control system. This is also where tracking stress, sleep, activity, and recovery can support the plan — not as a diagnostic test for IBS, but as a way to see the context around flares and recovery over time. (pmc.ncbi.nlm.nih.gov)
Probiotics
Probiotics are widely used, and the trial evidence is supportive but strain-specific. A 2025 meta-analysis found "Probiotics significantly reduced intestinal discomfort overall" and "Probiotics showed a clinically significant overall improvement" versus placebo, while "They were also well tolerated and did not increase adverse events". In the same analysis, pooled results showed improvement in IBS symptom severity, but effects varied by strain, symptom target, and IBS subtype. (pmc.ncbi.nlm.nih.gov)
That variability is the key patient point: “probiotic” is not one treatment. Different strains may do different things, and a product that helps bloating for one person may do little for constipation, diarrhea, or pain in another. NICE advises people who choose to try probiotics to use the product while monitoring the effect, and NIDDK recommends talking with a doctor before using probiotics or other complementary approaches. (nice.org.uk)
Medication
Medicines for IBS are chosen by subtype, dominant symptom, severity, and safety profile — for example, antispasmodic-type medicines for cramping pain, laxative or constipation-directed prescription options for IBS-C, and antimotility or diarrhea-directed prescription options for IBS-D. NICE states that pharmacological management should be based on the nature and severity of symptoms and that medication choice is determined by the predominant symptom or symptoms; ACG’s guideline also separates treatment recommendations by global IBS symptoms, IBS-C, and IBS-D. (nice.org.uk)
Over-the-counter options may be enough for milder or occasional symptoms, but prescription-only treatments can have meaningful cautions, restrictions, and side effects. NIDDK notes that doctors may recommend different medicines for IBS with diarrhea, IBS with constipation, and abdominal pain, and specifically advises following a doctor’s instructions and discussing possible side effects. This article does not give drug or dose instructions — see our IBS treatment page and talk to your clinician before starting, stopping, or combining IBS medicines. (niddk.nih.gov)
IBS, stress, and the mind-gut connection — the Welltory angle
IBS is not “all in your head.” It lives on the gut-brain axis: the two-way wiring between your digestive tract, nervous system, stress hormones, immune signaling, and microbiome. That is why IBS can be real even when routine tests do not show structural bowel damage, and why symptoms can shift with emotional stress, sleep loss, meals, constipation, diarrhea, or recovery debt. Your gut may move too fast or too slowly; the nerves in the gut wall may become more sensitive; your brain may turn up the volume on signals that another person barely notices. (my.clevelandclinic.org)
Stress matters here because it is not just a mood. It changes body chemistry. Chronic stress doesn't just feel linked to flares — it acts through the same pathway: "chronic stress and anxiety may significantly exacerbate symptoms through the upregulation of cortisol secretion, disrupting the gut microbiome and elevating visceral sensitivity". That helps explain why anxiety and IBS so often travel together: the gut can influence mood, and mood can influence gut motility, pain sensitivity, and urgency. (pmc.ncbi.nlm.nih.gov)
A wearable can't diagnose IBS and won't replace a clinician. IBS is diagnosed from your symptoms, history, and the workup your doctor uses to rule out other causes; there is no wearable metric, lab test, or sleep score that can “prove” IBS by itself. What tracking can do is give you context. If your flares cluster after high-stress days, poor sleep, low recovery, travel, intense workouts, late meals, or a run of bad nights, that pattern is useful. It turns “I think stress makes it worse” into a timeline you can bring to a gut-brain conversation with your doctor. (hopkinsmedicine.org)
That is the Welltory angle: we do not treat HRV, resting heart rate, or sleep as an IBS diagnosis. We treat them as the outside edge of the gut-brain story — signals that show what your nervous system was dealing with when your gut started shouting. In our own IBS cohort, the signal that separated people wasn't heart rate or sleep score; it was how they felt — especially brain fog — which fits the lived reality of a gut-brain condition better than a single “normal” wearable number. See the cohort box. Related reading: anxiety and cortisol.


Discounts for blog readers: up to 36% off
See what affects your energy, stress, sleep, and daily state with Welltory
This article is for educational purposes only and does not replace medical advice, diagnosis, or treatment. IBS is diagnosed by a symptom pattern, but the same IBS-like signals can also come from celiac disease, inflammatory bowel disease, infections, colon cancer, or other conditions. There is no single test that proves IBS. See a clinician promptly for red-flag signs — blood in the stool, unintended weight loss, anemia, fever, symptoms that wake you at night, a family history of bowel cancer or IBD, or new symptoms starting after age 50. Only a qualified clinician can diagnose IBS or prescribe medication for it.
Was this helpful?
Ask AI for a summary of page
Written by Jane Smorodnikova
The founder and CEO of Welltory. A recognized tech leader with two Master's degrees and experience at MIT, she has scaled Welltory to over 17 million users.
Written by Kseniia Iaroslavtseva
Reviewed by Anna Elitzur
With her medical degree, Anna reviews Welltory's health content for medical accuracy and alignment with current clinical guidelines and research.
References
- PMC12800576 — Pathophysiological Mechanisms and Nonpharmacological Interventions in Irritable Bowel Syndrome: Current Insights and Future Directions. Journal of Nutrition and Metabolism, 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC12800576/
- PMC12842271 / PMID 41598660 — Revisiting Abdominal Pain in IBS: From Pathophysiology to Targeted Management with Alverine Citrate/Simeticone. Journal of Clinical Medicine, 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC12842271/
- DOI 10.3389/fmed.2026.1740952 / PMID 41958585 — Map the prevalence of irritable bowel syndrome across China: a systematic review and meta-analysis. Frontiers in Medicine, 2026. https://pubmed.ncbi.nlm.nih.gov/41958585/
- PMC12842941 — Efficacy of Specific Probiotic Strains in Subtypes of Irritable Bowel Syndrome: Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicina, 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC12842941/
- PMC12967772 — Perceived Utility of Cognitive Behavioral Therapy in People With Bowel Disorders of Gut-Brain Interaction. Neurogastroenterology & Motility, 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC12800576/
- PMC12893123 / PMID 41684777 — Effectiveness of the low FODMAP diet in patients with irritable bowel syndrome and small intestine bacterial overgrowth syndrome. Frontiers in Nutrition, 2026. https://pubmed.ncbi.nlm.nih.gov/41684777/
- PMC12784227 / PMID 41505133 — Ethosuximide and Irritable Bowel Syndrome–Related Abdominal Pain: A Randomized Clinical Trial. JAMA Network Open, 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC12784227/
- PMID 33315591 — Lacy BE, Pimentel M, Brenner DM, et al. ACG Clinical Guideline: Management of Irritable Bowel Syndrome. American Journal of Gastroenterology, 2021. https://pubmed.ncbi.nlm.nih.gov/33315591/
- Rome IV diagnostic criteria for IBS — recurrent abdominal pain at least 1 day per week over the past 3 months, associated with at least 2 bowel-movement/stool-pattern features; symptom onset at least 6 months before diagnosis. https://www.ncbi.nlm.nih.gov/books/NBK534810/
- Rome IV IBS subtype stool-form cutoffs — IBS-C, IBS-D, IBS-M, and IBS-U classified by Bristol Stool Form Scale stool pattern on abnormal bowel-movement days. https://www.niddk.nih.gov/health-information/digestive-diseases/irritable-bowel-syndrome/definition-facts
- NICE CG61 — Irritable bowel syndrome in adults: diagnosis and management; diagnosis, red flags, diet/lifestyle advice, probiotics, psychological therapies, and pharmacological management by symptom pattern. https://www.nice.org.uk/guidance/cg61/chapter/recommendations
- NIDDK — Definition & Facts for Irritable Bowel Syndrome; IBS as a disorder of gut-brain interaction, visible-damage framing, IBS subtypes, and U.S. prevalence estimate. https://www.niddk.nih.gov/health-information/digestive-diseases/irritable-bowel-syndrome/definition-facts
- NIDDK — Symptoms & Causes of Irritable Bowel Syndrome; abdominal pain, bowel changes, bloating, mucus, menstrual timing, brain-gut interaction, motility, visceral sensitivity, infection, SIBO, food sensitivity, and genetics. https://www.niddk.nih.gov/health-information/digestive-diseases/irritable-bowel-syndrome/symptoms-causes
- NIDDK — Diagnosis of Irritable Bowel Syndrome; clinical diagnosis and testing used to rule out other causes. https://www.niddk.nih.gov/health-information/digestive-diseases/irritable-bowel-syndrome/diagnosis
- NIDDK — Treatment for Irritable Bowel Syndrome; diet, medicines by IBS pattern, and mental health therapies. https://www.niddk.nih.gov/health-information/digestive-diseases/irritable-bowel-syndrome/treatment
- NCBI Bookshelf / StatPearls — Irritable Bowel Syndrome; Rome IV criteria, red flags, differential diagnosis, evaluation, lifestyle/diet, low-FODMAP phases, and subtype-tailored management. https://www.ncbi.nlm.nih.gov/books/NBK534810/
- NCBI Bookshelf / StatPearls — The Low-FODMAP Diet in Clinical Practice: Evidence-Based Indications, Implementation, and Interprofessional Care. https://www.ncbi.nlm.nih.gov/books/NBK562224/
- Mayo Clinic — Irritable bowel syndrome: Symptoms and causes; long-term symptom pattern, no colorectal-cancer risk increase, triggers, and when to seek care. https://www.mayoclinic.org/diseases-conditions/irritable-bowel-syndrome/symptoms-causes/syc-20360016
- Mayo Clinic — Irritable bowel syndrome: Diagnosis and treatment; diagnosis by history/exam and rule-out testing, IBS types, red flags, lifestyle, diet, counseling, and medication categories. https://www.mayoclinic.org/diseases-conditions/irritable-bowel-syndrome/diagnosis-treatment/drc-20360064
- Cleveland Clinic — Irritable Bowel Syndrome (IBS); symptoms, subtypes, chronic manageable framing, and GI-tissue/cancer-risk patient education. https://www.mayoclinic.org/diseases-conditions/irritable-bowel-syndrome/symptoms-causes/syc-20360016
- Cleveland Clinic — Disorders of Gut-Brain Interaction (DGBI); gut-brain coordination framing for functional GI disorders. https://www.hopkinsmedicine.org/health/wellness-and-prevention/the-brain-gut-connection
- Johns Hopkins Medicine — Irritable Bowel Syndrome (IBS); Rome IV framing, gut-nerve hypersensitivity, symptoms, red flags, subtype descriptions, and stress/sleep/mood comorbidities. https://www.hopkinsmedicine.org/health/conditions-and-diseases/irritable-bowel-syndrome-ibs
- Johns Hopkins Medicine — Irritable Bowel Syndrome Treatment; individualized dietary, pharmacologic, behavioral, low-FODMAP, CBT, hypnotherapy, and probiotic approaches. https://www.hopkinsmedicine.org/health/treatment-tests-and-therapies/irritable-bowel-syndrome-treatment
- Johns Hopkins Medicine — FODMAP Diet: What You Need to Know; short-term low-FODMAP elimination and reintroduction structure. https://www.hopkinsmedicine.org/health/expert-qa/fodmap-diet-what-you-need-to-know
- MedlinePlus — Irritable Bowel Syndrome; patient-facing overview and safety framing. https://medlineplus.gov/irritablebowelsyndrome.html
- PMID 34490319 — A Low-FODMAP Diet Improves the Global Symptoms and Bowel Habits of Adult IBS Patients: A Systematic Review and Meta-Analysis. Frontiers in Nutrition, 2021. https://pubmed.ncbi.nlm.nih.gov/34490319/
- PMID 34376515 — Efficacy of a low FODMAP diet in irritable bowel syndrome: systematic review and network meta-analysis. Gut, 2022. https://pubmed.ncbi.nlm.nih.gov/34376515/
- PMID 39917138 — The Efficacy of the Low-FODMAP Diet in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis. Cureus, 2025. https://pubmed.ncbi.nlm.nih.gov/39917138/
- PMID 38479936 — Efficacy and safety of probiotics in irritable bowel syndrome: A systematic review and meta-analysis. https://pubmed.ncbi.nlm.nih.gov/38479936/
- PMC8529205 — Strain-specific and outcome-specific efficacy of probiotics for the treatment of irritable bowel syndrome: A systematic review and meta-analysis. https://pmc.ncbi.nlm.nih.gov/articles/PMC8529205/
- PMC4015203 — Gut-directed hypnotherapy evidence source cited for stress-directed and gut-brain approaches in IBS. https://www.hopkinsmedicine.org/health/treatment-tests-and-therapies/irritable-bowel-syndrome-treatment
- PMID 41077057 — IBS treatment review/source cited for the treatment FAQ.
- Welltory first-party cohort — `ibs__general__cohort.json`; anonymized aggregated self-report and wearable-data cohort, snapshot `persona_master`, 2026-07-06.


-2.jpg)




